European Crystallography Meeting delegates raise money for Cancer Research UK
October 1, 2013
The Woodlands, TX Cycling enthusiasts at the 28th European Crystallography Meeting (ECM) have used the occasion to raise money for Cancer Research. The ECMs are the general meetings of the European Crystallographic Association (ECA) and ECM28 was held in the UK at the University of Warwick from 25-29 August 2013. At the meeting, crystallographers and [...]
MTS EXPANDS REAL-TIME LAB MONITORING SOLUTION WITH THE RELEASE OF MTS ECHO™ 2.0
October 1, 2013
Eden Prairie, Minn. – MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high performance test systems and position sensors, today announced its release of the next generation of MTS Echo™ Software. The software gives MTS customers the ability to remotely monitor equipment activity throughout their lab from anywhere. Released in 2012, MTS Echo [...]
October 1, 2013
RESEARCH TRIANGLE PARK, N.C. – Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, today announced the Mobile Field Lab-3000 (MFL-3000) enables law enforcement to not only identify MDMA (street name “Molly”), but also to instantly identify the cutting agents used to make this potentially lethal drug. MDMA [...]
Ocean Optics Introduces Raman Microscope
October 1, 2013
Dunedin, Fla. – Now available from Ocean Optics is the IDRaman micro, a compact microscope designed for Raman measurements in research, quality control and quality assurance environments. The IDRaman micro is a versatile, high-performance analytical tool for applications where sampling requires careful focus and high spatial resolution to optimize the Raman signal. The new instrument [...]
AVIA Biosystems Automates Protein Stability Studies
October 1, 2013
Norton, Mass. – The new Model 2304 Automated Protein Denaturation System completely automates protein stability determinations using chemical denaturation, and is both the first instrument of its kind and the first instrument to be introduced by AVIA Biosystems of Norton, Mass. (www.aviabiosystems.com). Developed to facilitate the formulation of biologics in a safe and stable form, [...]
NanoString Technologies, Inc. and Fluidigm Corporation Settle Lawsuits
October 1, 2013
SEATTLE -- NanoString Technologies, Inc. (Nasdaq:NSTG) and Fluidigm Corporation (Nasdaq:FLDM) have agreed to settle lawsuits filed by Fluidigm in the United States and Singapore. In the U.S. case, Fluidigm charged NanoString with false advertising, unfair competition, and unlawful trade practices based on a comparison study of NanoString's Single Cell Gene Expression Assay on the nCounter® [...]
Emerson targets greatly expanded market for business critical applications
October 1, 2013
AUSTIN, TEXAS -- Emerson Process Management, a global business of Emerson (NYSE: EMR), is introducing an expanded product portfolio to address an untapped market for intelligent sensors in process manufacturing and production operations. This expanded “pervasive sensing” market extends the company’s focus beyond traditional process control and safety systems to now address customers’ need for [...]
Implant Sciences’ QS-B220 Explosives Trace Detector Receives STAC Certification in France
October 1, 2013
WILMINGTON, Mass. -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its TSA-approved QS-B220 desktop explosives trace detector (ETD) has been certified by Service Technique de l'Aviation Civile (STAC) in France. The QS-B220 is now certified for purchase and deployment to [...]
First urine-based cancer mutation monitoring test available from Trovagene
October 1, 2013
SAN DIEGO -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced availability of the first urine test for cancer mutation monitoring through the company's CLIA laboratory. The robustness of Trovagene's ultra-sensitive assay procedure has been demonstrated for detection of the BRAF V600E mutation from cell-free DNA in urine. This mutation commonly [...]
September 30, 2013
NEW YORK — Exosome Diagnostics today announced that it has selected Cedars-Sinai Medical Center to participate in an early technology access program for use of exosome RNA biofluid extraction kits for biomarker discovery in neo-natal and other disease settings. "The ability to monitor patients, particularly extreme premature infants, using real-time biofluid based genetics tests, may [...]
